Clinical Trial Update: Sintilimab Combined With Lenvatinib in Local Advanced Hepatocellular Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating sintilimab plus lenvatinib in locally advanced hepatocellular carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Lenvatinib (lenvatinib)
• Sintilimab (sintilimab)

Snippet

Sponsor: Baocai Xing | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: UNKNOWN